Skip to main content

Table 2 Drug use patterns and HCV care history among Karaj prison participants with positive HCV RNA

From: Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era

  Total People attended SVR visit
Characteristics, n % n = 60 n = 23
Drug use, ever 57 (100%) 22 (100%)
Age at first drug use, median (IQR) 18 (15, 22) 18 (16, 20)
Drug use within 6 months 38 (66.7%) 16 (69.6%)
Drug use in the last month 24 (42.1%) 9 (39.1%)
 Daily use 19 (79.2%) 7 (77.8%)
 Most commonly used drugs   
  Heroine and/or Methamphetamine 18 (75.0%) 8 (88.9%)
  Methadone 6 (25.0%) 1 (11.1%)
Injecting drug use, ever 28 (47.5%) 11 (50.0%)
Age at first injection 20 (18, 25) 20 (18, 27)
Injection within 6 months 7 (25.0%) 1 (9.1%)
Injection within the last month 4 (14.3%) 1 (9.1%)
  Daily injection 3 (75.0%) 1 (100%)
  Most commonly injected Heroine 3 (100%) 1 (100%)
  Shared needle or syringe 3 (75.0%) 0 (0.0%)
Smoking daily, current 50 (87.7%) 18 (78.3%)
Alcohol use, ever 10 (18.9%) 5 (23.8%)
Opioid agonist therapy (OAT)   
 Current 29 (55.8%) 10 (50.0%)
 History, not current 17 (32.7%) 7 (35.0%)
 Never 6 (11.5%) 3 (15.0%)
 HCV knowledge 4 (6.7%) 2 (8.7%)
 HCV screening, ever 10 (16.7%) 4 (17.4%)
 HCV treatment uptake, ever 3 (5.0%) 1 (5.3%)
 Willingness to receive HCV treatment 53 (93.0%) 19 (90.5%)
  1. Answered three out of five questions correctly